MAGELLAN HEALTH INC
CIK 0000019411
Revenue (TTM)
$7.21B
−0.5% YoY
Q3 Sep 2021
Net Income (TTM)
$44.74M
+2,209.0% YoY
Q3 Sep 2021
EPS Diluted (TTM)
$1.50
+2,167.4% YoY
Q3 Sep 2021
Gross Margin
2.5%
Q3 Sep 2021
Operating Margin
—
Q3 Sep 2021
Net Margin
0.6%
Q3 Sep 2021
Free Cash Flow (TTM)
$2.9M
Q3 Sep 2021
Cash
$376.7M
Q3 Sep 2021
Total Debt
—
Q3 Sep 2021
Shares Outstanding
26.33M sh
Q3 Sep 2021